Simulations Plus Receives Renewal of Large Pharmaceutical Software License

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that F. Hoffmann-LaRoche (“Roche”, NYSE: RHHBY) has issued a purchase order to renew their global software license for another year.

MORE ON THIS TOPIC